Royalty PharmaÂ Plc (RPRX) Financials

$63.96

$0.08 (0.13%)

As on 04-Sep-2026 16:25EDT

Market cap

$36,958 Mln

Revenue (TTM)

$2,536 Mln

P/E Ratio

34.4

P/B Ratio

4.2

Div. Yield

1.4 %

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	2,489.82	2,768.99	2,987.80	2,143.98	2,017.54
Cash Flow from Investing Activities	--	-1,614.18	-2,678.12	-2,072.79	-1,029.42	-1,870.28
Cash from Financing Activities	--	-1,185.97	361.15	-2,148.75	-944.86	385.11
Net Cash Inflow / Outflow	--	--	--	--	169.70	532.37

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	1.46	1.38	1.46	1.89	0.08	1.02
Cash EPS ($)	1.86	1.38	1.46	1.89	0.09	1.06
Adjusted Book Value ($)	15.33	11.57	11.79	10.84	10.77	16.88
Dividend per Share ($)	1.42	--	--	--	--	--
Cash Flow per Share ($)	--	4.45	4.70	4.96	4.10	3.32
Free Cash Flow per Share ($)	--	4.45	4.70	4.96	8.01	3.32

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	5.14	6.31	8.93	0.23	2.74
ROE (%)	4.21	11.49	12.75	18.67	0.54	4.91
ROA (%)	4.18	4.07	4.96	6.84	0.25	3.21
EBIT Margin (%)	67.47	68.62	57.10	63.37	18.69	61.47
Net Margin (%)	32.15	32.42	37.95	48.20	1.82	27.35
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	10.01	0.05	-0.04	0.05	-0.02	0.08
EBIT Growth (%)	-7.04	26.26	-13.38	256.95	-70.30	-24.30
Net Profit Growth (%)	-25.55	-10.25	-24.31	2,549.50	-93.09	-36.44
EPS Growth (%)	-16.11	-0.06	-0.23	22.00	-0.92	-0.59
Book Value Growth (%)	8.68	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	34.39	28.05	17.49	14.90	482.20	39.04
Price / Book Value	4.16	3.34	2.16	2.59	3.67	2.36
Dividend Yield (%)	1.42	--	--	--	--	--
EV/EBITDA	20.84	18.30	13.41	11.56	59.81	24.74
Close Price ($)	56.07	38.64	25.51	28.09	39.52	39.85
High Price ($)	57.22	41.24	31.66	39.92	44.75	53.23
Low Price ($)	34.08	25.40	24.05	25.92	36.15	34.86
Market Cap ($ Cr)	36,958.36	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	1.26	1.38	1.10	0.94	1.26	1.36
Short term debt to equity ratio	0.06	0.06	0.14	--	0.18	0.67
Current Ratio	1.29	0.97	1.44	7.90	2.19	16.81
Quick Ratio	1.29	--	--	--	2.19	16.81
Interest Coverage	4.74	5.30	5.73	7.97	2.22	8.47

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	35.07	37.16	1.19	0.95	1.64	2.98
Asset Turnover	0.13	0.13	0.13	0.14	0.13	0.12
Receivable days	--	69.93	3.98	4.58	8.56	8.57
Inventory Days	--	--	--	0.00	--	265.01
Payable days	--	1,553.83	7.11	7.52	2.73	6.61
Cash Conversion Cycle	--	--	--	-2.94	5.83	266.98

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Cashflow ($ Mln)